Respiratory Physiotherapy in Kovid-19 based on available evidence- A review study.

In late December 2019, the new coronavirus-2019 (2019-nCoV) caused the outbreak of pneumonia in Wuhan, China. The disease is currently being treated as a major health threat around the world that has claimed the lives of many people.Corona has infected about 200 countries, including Iran.According to world statistics, its mortality rate is 4.3%. The virus is classified on the Virus Classification Committee as Severe Acute Respiratory Syndrome. The early symptoms of Covid-19 include: pneumonia (with decreased oxygen levels, shortness of breath, irritable and dry cough, pharyngeal stimulation, sputum, risk of pulmonary fibrosis), fever, muscle aches and fatigue. To date, unfortunately, there are no approved vaccines or antiviral drugs to control this infection clinically. Therefore, prevention, infection control, and compliance with health principles are still a top priority for people.People with the disease develop significant respiratory problems from pneumonia, and consequently symptoms such as decreased oxygen levels, shortness of breath, irritable and dry cough, pharyngeal irritation, sputum, and risk of pulmonary fibrosis.The purpose of this review study is to evaluate the role of respiratory physiotherapy in the treatment of patients with covid-19 based on available evidence.